Translational Oncology (Dec 2021)
Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]
- Dabo Zhou,
- Liping Liu,
- Jingyu Liu,
- Yu Tang,
- Mengjia Xiao,
- Yikai Wang,
- Qiongzhi He,
- Zhe-Yu Hu,
- Quchang Ouyang
Affiliations
- Dabo Zhou
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China
- Liping Liu
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China
- Jingyu Liu
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China
- Yu Tang
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China
- Mengjia Xiao
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China
- Yikai Wang
- Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, 33022, USA
- Qiongzhi He
- Geneplus Beijing Institute, Beijing 102206, China
- Zhe-Yu Hu
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China; Corresponding authors at: No. 283, Tongzipo Road, Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, 410013, P.R. China.
- Quchang Ouyang
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China; Corresponding authors at: No. 283, Tongzipo Road, Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, 410013, P.R. China.
- Journal volume & issue
-
Vol. 14,
no. 12
p. 101226